Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 37-48 of 13290

Professor Lee Hae-young during the ESH 2025 symposium in Milan, Italy (Photo: Sky Labs)

Sky Labs at Forefront of Cuffless Blood Pressure Monitoring

KAYTUS Unveils Upgraded MotusAI to Accelerate LLM Deployment

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

MiNA Therapeutics Presents New Pre-Clinical Data from Sickle Cell Disease Program at the European Hematology Association 2025 Congress

Jennifer LaMothe Joins Kynisca as Chief People & Culture Officer

Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event

Encavis AG, RIC Energy and Voltalia, the middle-size energy companies that are setting the pace for renewables in Europe

Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales

Business Wire

Sky Labs at Forefront of Cuffless Blood Pressure Monitoring

KAYTUS Unveils Upgraded MotusAI to Accelerate LLM Deployment

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

MiNA Therapeutics Presents New Pre-Clinical Data from Sickle Cell Disease Program at the European Hematology Association 2025 Congress

Jennifer LaMothe Joins Kynisca as Chief People & Culture Officer

Supply Chain Leaders to Share Perspective on Tackling Tariffs, Trade, and Disruption During Exclusive Digital Event

Encavis AG, RIC Energy and Voltalia, the middle-size energy companies that are setting the pace for renewables in Europe

Galderma’s Nemluvio® (nemolizumab) Receives National Institute for Health and Care Excellence (NICE) Recommendation for Moderate-to-severe Atopic Dermatitis in England and Wales

BeOne Medicines Showcases Breakthrough Data in CLL and MCL at EHA 2025

Intuit Mailchimp Unveils Powerful New Suite of Tools at FWD: London to Help Businesses Unlock Their Customer Data

Infobip Named Among Top 75 in Fortune’s Europe’s Most Innovative Companies 2025

KBRA Releases Global ABS 2025: Day 2 Recap